MANIMARAN, D.; ELANGOVAN, N.; PALANISAMY, V. Anti-Tumorgenic Impact of Nano-Formulated Peptide HIF-Alpha Therapy by DMBA Induced Mammary Carcinoma in Rodent Type. Jordan Journal of Pharmaceutical Sciences, [S. l.], v. 17, n. 4, p. 783–793, 2024. DOI: 10.35516/jjps.v17i4.2482. Disponível em: https://jjournals.ju.edu.jo/index.php/jjps/article/view/2482. Acesso em: 3 dec. 2025.